日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Validation of plasmin-cleaved VWF as a biomarker for microthrombosis in Japanese patients with acute immune-mediated TTP

验证纤溶酶裂解的VWF作为日本急性免疫介导性TTP患者微血栓形成的生物标志物。

El Otmani, Hinde; Tersteeg, Claudia; Vanhoorelbeke, Karen; Matsumoto, Masanori; Sakai, Kazuya

Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease.

急性和慢性肝病患者中纤溶酶介导的血管性血友病因子蛋白水解

El Otmani Hinde, Stamouli Marilena, Adelmeijer Jelle, Bernal William, Maas Coen, Patel Vishal C, Lisman Ton

Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis

纤溶酶裂解的血管性血友病因子作为微血管血栓形成的生物标志物

El Otmani, Hinde; Frunt, Rowan; Smits, Simone; Barendrecht, Arjan D; de Maat, Steven; Fijnheer, Rob; Lenting, Peter J; Tersteeg, Claudia

Targeted SERPIN (TaSER): A dual-action antithrombotic agent that targets platelets for SERPIN delivery.

靶向丝氨酸蛋白酶抑制剂(TaSER):一种双重作用的抗血栓药物,靶向血小板递送丝氨酸蛋白酶抑制剂

Sanrattana Wariya, Smits Simone, Barendrecht Arjan D, van Kleef Nadine D, El Otmani Hinde, Zivkovic Minka, Roest Mark, Renné Thomas, Clark Chantal C, de Maat Steven, Maas Coen